참고문헌 (136)

1. Genes Dev. MS Hayden 18 2195 2004 10.1101/gad.1228704 Hayden, M. S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195-2224 (2004). This review of the mechanisms of NF-κB activation provides a comprehensive analysis of the NF-κB-signalling pathway. 

   상세보기

2. Trends Immunol. G Bonizzi 25 280 2004 10.1016/j.it.2004.03.008 Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288 (2004). 

   상세보기

3. Oncogene S Gerondakis 18 6888 1999 10.1038/sj.onc.1203236 Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T. & Grumont, R. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene 18, 6888-6895 (1999). 

   상세보기

4. Cell Death Differ. M Pasparakis 13 861 2006 10.1038/sj.cdd.4401870 Pasparakis, M., Luedde, T. & Schmidt-Supprian, M. Dissection of the NF-κB signalling cascade in transgenic and knockout mice. Cell Death Differ. 13, 861-872 (2006). Genetic experiments in mice provide much of the basis for our understanding of the NF-κB and IKK pathway. Reference 3 summarizes fundamental information about different NF-κB-, IκB- and IKK-knockout mouse phenotypes. Reference 4 describes how these mice have been used to study the role of the NF-κB and IKK pathway in physiological processes and human diseases. These reviews are both essential reading. 

   상세보기

5. Oncogene HL Pahl 18 6853 1999 10.1038/sj.onc.1203239 Pahl, H. L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866 (1999). 

   상세보기

6. Cell Death Differ. ND Perkins 13 759 2006 10.1038/sj.cdd.4401838 Perkins, N. D. & Gilmore, T. D. Good cop, bad cop: the different faces of NF-κB. Cell Death Differ. 13, 759-772 (2006). Inhibiting NF-κB might not be all good news. This review discusses how NF-κB functions can vary depending on the biological context, and in some cases display apparently contradictory roles. 

   상세보기

7. Nature Rev. Drug Discov. M Karin 3 17 2004 10.1038/nrd1279 Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-κB system: a treasure trove for drug development. Nature Rev. Drug Discov. 3, 17-26 (2004). 

   상세보기

8. Cell Death Differ. HJ Kim 13 738 2006 10.1038/sj.cdd.4401877 Kim, H. J., Hawke, N. & Baldwin, A. S. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 13, 738-747 (2006). Targeting the NF-κB pathway is now recognized as a potential therapy for many inflammatory diseases and cancer. References 7 and 8 provide the rationale for why this is the case and describe the strategies that can be used. 

   상세보기

9. J. Mol. Med. A Kumar 82 434 2004 10.1007/s00109-004-0555-y Kumar, A., Takada, Y., Boriek, A. M. & Aggarwal, B. B. Nuclear factor-κB: its role in health and disease. J. Mol. Med. 82, 434-448 (2004). 

   상세보기

10. EMBO J. A Hoffmann 22 5530 2003 10.1093/emboj/cdg534 Hoffmann, A., Leung, T. H. & Baltimore, D. Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J. 22, 5530-5539 (2003). 

    상세보기

11. EMBO J. P Dobrzanski 13 4608 1994 10.1002/j.1460-2075.1994.tb06782.x Dobrzanski, P., Ryseck, R. P. & Bravo, R. Differential Interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J. 13, 4608-4616 (1994). 

    상세보기

12. Oncogene ND Perkins 25 6717 2006 10.1038/sj.onc.1209937 Perkins, N. D. Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene 25, 6717-6730 (2006). 

    상세보기

13. Oncogene ND Perkins 22 7553 2003 10.1038/sj.onc.1207139 Perkins, N. D. Oncogenes, tumor suppressors and p52 NF-κB. Oncogene 22, 7553-7556 (2003). 

    상세보기

14. Cell L Lin 92 819 1998 10.1016/S0092-8674(00)81409-9 Lin, L., DeMartino, G. N. & Greene, W. C. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92, 819-828 (1998). 

    상세보기

15. Mol. Cell. Biol. S Cohen 24 475 2004 10.1128/MCB.24.1.475-486.2004 Cohen, S., Achbert-Weiner, H. & Ciechanover, A. Dual effects of IκB kinase β-mediated phosphorylation on p105 fate: SCF(β-TrCP)-dependent degradation and SCF(β-TrCP)-independent processing. Mol. Cell. Biol. 24, 475-486 (2004). 

    상세보기

16. EMBO J. AK Moorthy 25 1945 2006 10.1038/sj.emboj.7601081 Moorthy, A. K. et al. The 20S proteasome processes NF-κB1 p105 into p50 in a translation-independent manner. EMBO J. 25, 1945-1956 (2006). 

    상세보기

17. Cell Death Differ. T Kawai 13 816 2006 10.1038/sj.cdd.4401850 Kawai, T. & Akira, S. TLR signaling. Cell Death Differ. 13, 816-825 (2006). 

    상세보기

18. Nature Cell Biol. ZJ Chen 7 758 2005 10.1038/ncb0805-758 Chen, Z. J. Ubiquitin signalling in the NF-κB pathway. Nature Cell Biol. 7, 758-765 (2005). 

    상세보기

19. EMBO Rep. D Krappmann 6 321 2005 10.1038/sj.embor.7400380 Krappmann, D. & Scheidereit, C. A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways. EMBO Rep. 6, 321-326 (2005). NEMO-dependent activation of IKKβ involves a complex, ubiquitin-based signalling pathway that is comprehensively described in references 18 and 19. 

    상세보기

20. Curr. Biol. KA Burns 14 R1040 2004 10.1016/j.cub.2004.11.040 Burns, K. A. & Martinon, F. Inflammatory diseases: is ubiquitinated NEMO at the hub? Curr. Biol. 14, R1040-R1042 (2004). 

    상세보기

21. Nature Immunol. M Yamamoto 7 962 2006 10.1038/ni1367 Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nature Immunol. 7, 962-970 (2006). 

    상세보기

22. Cell Death Differ. S Janssens 13 773 2006 10.1038/sj.cdd.4401843 Janssens, S. & Tschopp, J. Signals from within: the DNA-damage-induced NF-κB response. Cell Death Differ. 13, 773-784 (2006). 

    상세보기

23. Science ZH Wu 311 1141 2006 10.1126/science.1121513 Wu, Z. H., Shi, Y., Tibbetts, R. S. & Miyamoto, S. Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli. Science 311, 1141-1146 (2006). 

    상세보기

24. J. Clin. Invest. JL Luo 115 2625 2005 10.1172/JCI26322 Luo, J. L., Kamata, H. & Karin, M. IKK/NF-κB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest. 115, 2625-2632 (2005). 

    상세보기

25. Oncogene J Kucharczak 22 8961 2003 10.1038/sj.onc.1207230 Kucharczak, J., Simmons, M. J., Fan, Y. J. & Gelinas, C. To be, or not to be: NF-κB is the answer - role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22, 8961-8982 (2003). Comprehensive review of the complexities surrounding NF-κB-dependent regulation of apoptosis. 

    상세보기

26. Nature Med. O Herrmann 11 1322 2005 10.1038/nm1323 Herrmann, O. et al. IKK mediates ischemia-induced neuronal death. Nature Med. 11, 1322-1329 (2005). 

    상세보기

27. Development FO Baxter 133 3485 2006 10.1242/dev.02502 Baxter, F. O. et al. IKKβ/2 induces TWEAK and apoptosis in mammary epithelial cells. Development 133, 3485-3494 (2006). 

    상세보기

28. Cell MC Hu 117 225 2004 10.1016/S0092-8674(04)00302-2 Hu, M. C. et al. IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225-237 (2004). 

    상세보기

29. Mol. Cell. Biol. SI Gringhuis 25 6454 2005 10.1128/MCB.25.15.6454-6463.2005 Gringhuis, S. I., Garcia-Vallejo, J. J., van Het Hof, B. & van Dijk, W. Convergent actions of IκB kinase β and protein kinase Cδ modulate mRNA stability through phosphorylation of 14-3-3β complexed with tristetraprolin. Mol. Cell. Biol. 25, 6454-6463 (2005). 

    상세보기

30. J. Biol. Chem. Z Gao 277 48115 2002 10.1074/jbc.M209459200 Gao, Z. et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J. Biol. Chem. 277, 48115-48121 (2002). 

    상세보기

31. Mol. Endocrinol. J He 20 114 2006 10.1210/me.2005-0107 He, J. et al. Interleukin-1α inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol. Endocrinol. 20, 114-124 (2006). 

    상세보기

32. J. Cell. Biol. Y Nakamori 173 665 2006 10.1083/jcb.200601065 Nakamori, Y. et al. Myosin motor Myo1c and its receptor NEMO/IKK-γ promote TNF-α-induced serine307 phosphorylation of IRS-1. J. Cell. Biol. 173, 665-671 (2006). 

    상세보기

33. Mol. Cell E Wegener 23 13 2006 10.1016/j.molcel.2006.05.027 Wegener, E. et al. Essential role for IκB kinase β in remodelling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23, 13-23 (2006). 

    상세보기

34. Mol. Cell. Biol. S Beinke 24 9658 2004 10.1128/MCB.24.21.9658-9667.2004 Beinke, S., Robinson, M. J., Hugunin, M. & Ley, S. C. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell. Biol. 24, 9658-9667 (2004). 

    상세보기

35. Mol. Cell. Biol. M Waterfield 24 6040 2004 10.1128/MCB.24.13.6040-6048.2004 Waterfield, M., Jin, W., Reiley, W., Zhang, M. & Sun, S. C. IκB kinase is an essential component of the Tpl2 signaling pathway. Mol. Cell. Biol. 24, 6040-6048 (2004). References 34 and 35 describe how IKKβ-induced proteolysis of p105 results in TPL2 and MAP kinase-pathway activation. 

    상세보기

36. Nature Cell Biol. T Bouwmeester 6 97 2004 10.1038/ncb1086 Bouwmeester, T. et al. A physical and functional map of the human TNF-α NF-κB signal transduction pathway. Nature Cell Biol. 6, 97-105 (2004). 

    상세보기

37. J. Biol. Chem. J Zhang 279 17819 2004 10.1074/jbc.M310737200 Zhang, J., Xu, L. G., Han, K. J. & Shu, H. B. Identification of a ZU5 and death domain-containing inhibitor of NF-κB. J. Biol. Chem. 279, 17819-17825 (2004). 

    상세보기

38. Biochem. Biophys. Res. Commun. Z Li 309 980 2003 10.1016/j.bbrc.2003.08.104 Li, Z., Zhang, J., Chen, D. & Shu, H. B. Casper/c-FLIP is physically and functionally associated with NF-κB1 p105. Biochem. Biophys. Res. Commun. 309, 980-985 (2003). 

    상세보기

39. Oncogene R Ferrier 18 995 1999 10.1038/sj.onc.1202374 Ferrier, R. et al. Physical interaction of the bHLH LYL1 protein and NF-κB1 p105. Oncogene 18, 995-1005 (1999). 

    상세보기

40. Proc. Natl Acad. Sci. USA S Lee 101 17416 2004 10.1073/pnas.0408061101 Lee, S. et al. IκB kinase β phosphorylates Dok1 serines in response to TNF, IL-1, or γ radiation. Proc. Natl Acad. Sci. USA 101, 17416-17421 (2004). 

    상세보기

41. Mol. Cell. Biol. SD Westerheide 21 8428 2001 10.1128/MCB.21.24.8428-8436.2001 Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L. & Baldwin, A. S. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition. Mol. Cell. Biol. 21, 8428-8436 (2001). 

    상세보기

42. Mol. Cell. Biol. S Rocha 23 4713 2003 10.1128/MCB.23.13.4713-4727.2003 Rocha, S., Martin, A. M., Meek, D. W. & Perkins, N. D. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1. Mol. Cell. Biol. 23, 4713-4727 (2003). 

    상세보기

43. Mol. Cell. Biol. RC Wu 22 3549 2002 10.1128/MCB.22.10.3549-3561.2002 Wu, R. C. et al. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by IκB kinase. Mol. Cell. Biol. 22, 3549-3561 (2002). 

    상세보기

44. Mol. Cell KJ Park 18 71 2005 10.1016/j.molcel.2005.03.006 Park, K. J., Krishnan, V., O'Malley, B. W., Yamamoto, Y. & Gaynor, R. B. Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol. Cell 18, 71-82 (2005). A good example of NF-κB-independent regulation of transcription by IKKα. 

    상세보기

45. Mol. Biol. Cell C Albanese 14 585 2003 10.1091/mbc.02-06-0101 Albanese, C. et al. IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol. Biol. Cell 14, 585-599 (2003). 

    상세보기

46. Cell. Signal. N Carayol 18 1941 2006 10.1016/j.cellsig.2006.02.014 Carayol, N. & Wang, C. Y. IKKα stabilizes cytosolic β-catenin by inhibiting both canonical and non-canonical degradation pathways. Cell. Signal. 18, 1941-1946 (2006). 

    상세보기

47. J. Biol. Chem. C Lamberti 276 42276 2001 10.1074/jbc.M104227200 Lamberti, C. et al. Regulation of β-catenin function by the IκB kinases. J. Biol. Chem. 276, 42276-42286 (2001). 

    상세보기

48. Cancer Cell JO Deng 2 323 2002 10.1016/S1535-6108(02)00154-X Deng, J. O. et al. β-catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2, 323-334 (2002). 

    상세보기

49. Nature JH Kim 434 921 2005 10.1038/nature03452 Kim, J. H. et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434, 921-926 (2005). 

    상세보기

50. J. Biol. Chem. YT Kwak 280 33945 2005 10.1074/jbc.M506206200 Kwak, Y. T. et al. IκB kinase α regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J. Biol. Chem. 280, 33945-33952 (2005). 

    상세보기

51. J. Biol. Chem. Z Tu 281 6699 2006 10.1074/jbc.M512439200 Tu, Z. et al. IKK α regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J. Biol. Chem. 281, 6699-6706 (2006). 

    상세보기

52. Mol. Cell JE Hoberg 16 245 2004 10.1016/j.molcel.2004.10.010 Hoberg, J. E., Yeung, F. & Mayo, M. W. SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol. Cell 16, 245-255 (2004). 

    상세보기

53. Nature K Hoshino 440 949 2006 10.1038/nature04641 Hoshino, K. et al. IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9. Nature 440, 949-953 (2006). 

    상세보기

54. Nature V Anest 423 659 2003 10.1038/nature01648 Anest, V. et al. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423, 659-663 (2003). 

    상세보기

55. Nature Y Yamamoto 423 655 2003 10.1038/nature01576 Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y. T. & Gaynor, R. B. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655-659 (2003). 

    상세보기

56. EMBO J. A Soloaga 22 2788 2003 10.1093/emboj/cdg273 Soloaga, A. et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788-2797 (2003). 

    상세보기

57. J. Biol. Chem. EA Duncan 281 12521 2006 10.1074/jbc.M513333200 Duncan, E. A., Anest, V., Cogswell, P. & Baldwin, A. S. The kinases MSK1 and MSK2 are required for epidermal growth factor-induced, but not tumor necrosis factor-induced, histone H3 Ser10 phosphorylation. J. Biol. Chem. 281, 12521-12525 (2006). 

    상세보기

58. Nature Immunol. S Saccani 3 69 2002 10.1038/ni748 Saccani, S., Pantano, S. & Natoli, G. p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nature Immunol. 3, 69-75 (2002). 

    상세보기

59. Nature YL Hu 410 710 2001 10.1038/35070605 Hu, Y. L. et al. IKKα controls formation of the epidermis independently of NF-κB. Nature 410, 710-714 (2001). 

    상세보기

60. Dev. Cell A Ohazama 6 219 2004 10.1016/S1534-5807(04)00024-3 Ohazama, A. et al. A dual role for IKKα in tooth development. Dev. Cell 6, 219-227 (2004). 

    상세보기

61. J. Biol. Chem. UN Verma 279 3509 2004 10.1074/jbc.M309300200 Verma, U. N., Yamamoto, Y., Prajapati, S. & Gaynor, R. B. Nuclear role of I κB Kinase-γ/NF-κB essential modulator (IKKγ/NEMO) in NF-κB-dependent gene expression. J. Biol. Chem. 279, 3509-3515 (2004). 

    상세보기

62. J. Biol. Chem. CP Bracken 280 14240 2005 10.1074/jbc.M409987200 Bracken, C. P., Whitelaw, M. L. & Peet, D. J. Activity of hypoxia-inducible factor 2α is regulated by association with the NF-κB essential modulator. J. Biol. Chem. 280, 14240-14251 (2005). 

    상세보기

63. Biochemistry J Li 42 13476 2003 10.1021/bi035390r Li, J., Joo, S. H. & Tsai, M. D. An NF-κB-specific inhibitor, IκBα, binds to and inhibits cyclin-dependent kinase 4. Biochemistry 42, 13476-13483 (2003). 

    상세보기

64. J. Biol. Chem. NS Chang 277 10323 2002 10.1074/jbc.M106607200 Chang, N. S. The non-ankyrin C terminus of IκBα physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-β1-mediated growth suppression. J. Biol. Chem. 277, 10323-10331 (2002). 

    상세보기

65. Oncogene M Zhou 22 8137 2003 10.1038/sj.onc.1206911 Zhou, M., Gu, L., Zhu, N., Woods, W. G. & Findley, H. W. Transfection of a dominant-negative mutant NF-κB inhibitor (IκBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53. Oncogene 22, 8137-8144 (2003). 

    상세보기

66. BMC Immunol. DH Dreyfus 6 12 2005 10.1186/1471-2172-6-12 Dreyfus, D. H., Nagasawa, M., Gelfand, E. W. & Ghoda, L. Y. Modulation of p53 activity by IκBα: evidence suggesting a common phylogeny between NF-κB and p53 transcription factors. BMC Immunol. 6, 12 (2005). 

    상세보기

67. J. Virol. BY Wu 71 3161 1997 10.1128/jvi.71.4.3161-3167.1997 Wu, B. Y., Woffendin, C., MacLachlan, I. & Nabel, G. J. Distinct domains of IκB-α inhibit human immunodeficiency virus type 1 replication through NF-κB and Rev. J. Virol. 71, 3161-3167 (1997). 

    상세보기

68. Proc. Natl Acad. Sci. USA C Aguilera 101 16537 2004 10.1073/pnas.0404429101 Aguilera, C., Hoya-Arias, R., Haegeman, G., Espinosa, L. & Bigas, A. Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression. Proc. Natl Acad. Sci. USA 101, 16537-16542 (2004). 

    상세보기

69. Mol. Cell HH Zhong 1 661 1998 10.1016/S1097-2765(00)80066-0 Zhong, H. H., Voll, R. E. & Ghosh, S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1, 661-671 (1998). 

    상세보기

70. Mol. Cell. Biol. JE Hoberg 26 457 2006 10.1128/MCB.26.2.457-471.2006 Hoberg, J. E., Popko, A. E., Ramsey, C. S. & Mayo, M. W. IκB kinase α-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol. Cell. Biol. 26, 457-471 (2006). Interesting paper describing the complexities of NF-κB-mediated gene regulation, including the role of co-activators, co-repressors and post-translational modifications. 

    상세보기

71. Nature Rev. Mol. Cell Biol. LF Chen 5 392 2004 10.1038/nrm1368 Chen, L. F. & Greene, W. C. Shaping the nuclear action of NF-κB. Nature Rev. Mol. Cell Biol. 5, 392-401 (2004). 

    상세보기

72. Mol. Cell S Rocha 12 15 2003 10.1016/S1097-2765(03)00223-5 Rocha, S., Campbell, K. J. & Perkins, N. D. p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor. Mol. Cell 12, 15-25 (2003). 

    상세보기

73. EMBO J. S Rocha 24 1157 2005 10.1038/sj.emboj.7600608 Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K. & Perkins, N. D. Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J. 24, 1157-1169 (2005). Describes how RelA can repress as well as activate transcription and how these contrasting functions can result from subunit phosphorylation and be linked to tumour-suppressor function. 

    상세보기

74. Cancer Res. KJ Campbell 66 929 2006 10.1158/0008-5472.CAN-05-2234 Campbell, K. J., Witty, J. M., Rocha, S. & Perkins, N. D. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation. Cancer Res. 66, 929-935 (2006). 

    상세보기

75. Mol. Cell KJ Campbell 13 853 2004 10.1016/S1097-2765(04)00131-5 Campbell, K. J., Rocha, S. & Perkins, N. D. Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB. Mol. Cell 13, 853-865 (2004). 

    상세보기

76. Oncogene E Strozyk 25 6239 2006 10.1038/sj.onc.1209655 Strozyk, E., Poppelmann, B., Schwarz, T. & Kulms, D. Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 25, 6239-6251 (2006). 

    상세보기

77. Mol. Cell J Liu 21 467 2006 10.1016/j.molcel.2005.12.020 Liu, J. et al. NF-κB is required for UV-induced JNK activation via induction of PKCδ. Mol. Cell 21, 467-480 (2006). 

    상세보기

78. J. Biol. Chem. J Anrather 280 244 2005 10.1074/jbc.M409344200 Anrather, J., Racchumi, G. & Iadecola, C. cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-κB. J. Biol. Chem. 280, 244-252 (2005). 

    상세보기

79. J. Clin. Oncol. JE Thompson 22 4217 2004 10.1200/JCO.2004.01.103 Thompson, J. E. & Thompson, C. B. Putting the rap on Akt. J. Clin. Oncol. 22, 4217-4226 (2004). 

    상세보기

80. J. Biol. Chem. LV Madrid 276 18934 2001 10.1074/jbc.M101103200 Madrid, L. V., Mayo, M. W., Reuther, J. Y. & Baldwin, A. S. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276, 18934-18940 (2001). 

    상세보기

81. Oncogene SJ Jeong 24 6719 2005 10.1038/sj.onc.1208825 Jeong, S. J., Pise-Masison, C. A., Radonovich, M. F., Park, H. U. & Brady, J. N. Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24, 6719-6728 (2005). 

    상세보기

82. J. Biol. Chem. D Haller 277 38168 2002 10.1074/jbc.M205737200 Haller, D., Russo, M. P., Sartor, R. B. & Jobin, C. IKKβ and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-κB activation in both primary and intestinal epithelial cell lines. J. Biol. Chem. 277, 38168-38178 (2002). 

    상세보기

83. J. Immunol. I Mattioli 172 6336 2004 10.4049/jimmunol.172.10.6336 Mattioli, I. et al. Transient and selective NF-κB p65 serine 536 phosphorylation induced by T cell costimulation is mediated by IκB kinase β and controls the kinetics of p65 nuclear import. J. Immunol. 172, 6336-6344 (2004). 

    상세보기

84. J. Biol. Chem. J Bohuslav 279 26115 2004 10.1074/jbc.M313509200 Bohuslav, J., Chen, L. F., Kwon, H., Mu, Y. & Greene, W. C. p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279, 26115-26125 (2004). 

    상세보기

85. Nature T Lawrence 434 1138 2005 10.1038/nature03491 Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V. & Karin, M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005). 

    상세보기

86. Int. J. Biochem. Cell. Biol. ND Perkins 29 1433 1997 10.1016/S1357-2725(97)00088-5 Perkins, N. D. Achieving transcriptional specificity with NF-κB. Int. J. Biochem. Cell. Biol. 29, 1433-1448 (1997). 

    상세보기

87. Nature Immunol. G Natoli 6 439 2005 10.1038/ni1196 Natoli, G., Saccani, S., Bosisio, D. & Marazzi, I. Interactions of NF-κB with chromatin: the art of being at the right place at the right time. Nature Immunol. 6, 439-445 (2005). Interesting review that discusses the importance of chromatin structure, including histone phosphorylation, for the regulation of NF-κB-dependent gene expression. 

    상세보기

88. Curr. Opin. Genet. Dev. M Merika 11 205 2001 10.1016/S0959-437X(00)00180-5 Merika, M. & Thanos, D. Enhanceosomes. Curr. Opin. Genet. Dev. 11, 205-208 (2001). 

    상세보기

89. Cell JV Falvo 83 1101 1995 10.1016/0092-8674(95)90137-X Falvo, J. V., Thanos, D. & Maniatis, T. Reversal of intrinsic DNA bends in the IFN-b gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-1111 (1995). 

    상세보기

90. Cell D Thanos 83 1091 1995 10.1016/0092-8674(95)90136-1 Thanos, D. & Maniatis, T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100 (1995). 

    상세보기

91. J. Biol. Chem. NR Chapman 275 4719 2000 10.1074/jbc.275.7.4719 Chapman, N. R. & Perkins, N. D. Inhibition of the RelA(p65) NF-κB subunit by Egr-1. J. Biol. Chem. 275, 4719-4725 (2000). 

    상세보기

92. Cell Death Differ. G Natoli 13 693 2006 10.1038/sj.cdd.4401880 Natoli, G. & De Santa, F. Shaping alternative NF-κB-dependent gene expression programs: new clues to specificity. Cell Death Differ. 13, 693-696 (2006). 

    상세보기

93. Mol. Cell. Biol. A Kumar 25 5893 2005 10.1128/MCB.25.14.5893-5903.2005 Kumar, A., Lin, Z., SenBanerjee, S. & Jain, M. K. Tumor necrosis factor α-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-κB and histone deacetylases. Mol. Cell. Biol. 25, 5893-5903 (2005). 

    상세보기

94. EMBO J. K Schumm 25 4820 2006 10.1038/sj.emboj.7601343 Schumm, K., Rocha, S., Caamano, J. & Perkins, N. D. Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. EMBO J. 25, 4820-4832 (2006). 

    상세보기

95. Proc. Natl Acad. Sci. USA N Nadiminty 103 7264 2006 10.1073/pnas.0509808103 Nadiminty, N. et al. Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation. Proc. Natl Acad. Sci. USA 103, 7264-7269 (2006). 

    상세보기

96. Genes Dev. OH Kramer 20 473 2006 10.1101/gad.364306 Kramer, O. H. et al. Acetylation of Stat1 modulates NF-κB activity. Genes Dev. 20, 473-485 (2006). 

    상세보기

97. EMBO J. D Bosisio 25 798 2006 10.1038/sj.emboj.7600977 Bosisio, D. et al. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-κB-dependent gene activity. EMBO J. 25, 798-810 (2006). 

    상세보기

98. Mol. Cell M Merika 1 277 1998 10.1016/S1097-2765(00)80028-3 Merika, M., Williams, A. J., Chen, G. Y., Collins, T. & Thanos, D. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription. Mol. Cell 1, 277-287 (1998). 

    상세보기

99. Mol. Cell. Biol. E Ainbinder 22 6354 2002 10.1128/MCB.22.18.6354-6362.2002 Ainbinder, E. et al. Mechanism of rapid transcriptional induction of tumor necrosis factor α-responsive genes by NF-κB. Mol. Cell. Biol. 22, 6354-6362 (2002). 

    상세보기

100. Dev. Biol. A Stathopoulos 246 57 2002 10.1006/dbio.2002.0652 Stathopoulos, A. & Levine, M. Dorsal gradient networks in the Drosophila embryo. Dev. Biol. 246, 57-67 (2002). 

     상세보기

101. J. Biol. Chem. H Jono 279 36171 2004 10.1074/jbc.M406638200 Jono, H. et al. NF-κB is essential for induction of CYLD, the negative regulator of NF-κB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 279, 36171-36174 (2004). 

     상세보기

102. Nature IE Wertz 430 694 2004 10.1038/nature02794 Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699 (2004). 

     상세보기

103. Nature E Trompouki 424 793 2003 10.1038/nature01803 Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424, 793-796 (2003). 

     상세보기

104. Nature TR Brummelkamp 424 797 2003 10.1038/nature01811 Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003). 

     상세보기

105. Nature A Kovalenko 424 801 2003 10.1038/nature01802 Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801-805 (2003). 

     상세보기

106. Cell R Massoumi 125 665 2006 10.1016/j.cell.2006.03.041 Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A. & Fassler, R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125, 665-677 (2006). 

     상세보기

107. Mol. Cell. Biol. D Krappmann 24 6488 2004 10.1128/MCB.24.14.6488-6500.2004 Krappmann, D. et al. The IκB kinase complex and NF-κB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol. Cell. Biol. 24, 6488-6500 (2004). This paper is an excellent example of how NF-κB-induced genes, in this case AP1 family members, influence a second wave of NF-κB-dependent gene expression. 

     상세보기

108. Science SL Werner 309 1857 2005 10.1126/science.1113319 Werner, S. L., Barken, D. & Hoffmann, A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309, 1857-1861 (2005). 

     상세보기

109. Science MW Covert 309 1854 2005 10.1126/science.1112304 Covert, M. W., Leung, T. H., Gaston, J. E. & Baltimore, D. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309, 1854-1857 (2005). 

     상세보기

110. J. Biol. Chem. C Wietek 278 50923 2003 10.1074/jbc.M308135200 Wietek, C., Miggin, S. M., Jefferies, C. A. & O'Neill, L. A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-κ. J. Biol. Chem. 278, 50923-50931 (2003). 

     상세보기

111. Cell Death Differ. S Papa 13 712 2006 10.1038/sj.cdd.4401865 Papa, S. et al. The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 13, 712-729 (2006). 

     상세보기

112. Cell Death Differ. H Nakano 13 730 2006 10.1038/sj.cdd.4401830 Nakano, H. et al. Reactive oxygen species mediate crosstalk between NF-κB and JNK. Cell Death Differ. 13, 730-737 (2006). References 111 nd 112 are comprehensive reviews that discuss the mechanisms linking NF-κB activity to the JNK-signalling pathway. 

     상세보기

113. Cell H Kamata 120 649 2005 10.1016/j.cell.2004.12.041 Kamata, H. et al. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661 (2005). 

     상세보기

114. J. Cell Biol. JY Zhang 168 561 2005 10.1083/jcb.200411060 Zhang, J. Y., Tao, S., Kimmel, R. & Khavari, P. A. CDK4 regulation by TNFR1 and JNK is required for NF-κB-mediated epidermal growth control. J. Cell Biol. 168, 561-566 (2005). 

     상세보기

115. Nature Rev. Cancer KH Vousden 2 594 2002 10.1038/nrc864 Vousden, K. H. & Lu, X. Live or let die: the cell's response to p53. Nature Rev. Cancer 2, 594-604 (2002). 

     상세보기

116. Cancer Cell V Tergaonkar 1 493 2002 10.1016/S1535-6108(02)00068-5 Tergaonkar, V., Pando, M., Vafa, O., Wahl, G. & Verma, I. p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy. Cancer Cell 1, 493-503 (2002). Shows how, in some circumstances, the NF-κB and IKK pathway can suppress p53 activity through inducing HDM2 (or MDM2) expression. 

     상세보기

117. Genes Dev. D Kashatus 20 225 2006 10.1101/gad.1352206 Kashatus, D., Cogswell, P. & Baldwin, A. S. Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes Dev. 20, 225-235 (2006). 

     상세보기

118. Mol. Cell. Biol. GA Webster 19 3485 1999 10.1128/MCB.19.5.3485 Webster, G. A. & Perkins, N. D. Transcriptional cross talk between NF-κB and p53. Mol. Cell. Biol. 19, 3485-3495 (1999). 

     상세보기

119. Nature KM Ryan 404 892 2000 10.1038/35009130 Ryan, K. M., Ernst, M. K., Rice, N. R. & Vousden, K. H. Role of NF-κB in p53-mediated programmed cell death. Nature 404, 892-897 (2000). 

     상세보기

120. J. Biol. Chem. S Fujioka 279 27549 2004 10.1074/jbc.M313435200 Fujioka, S. et al. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-κB. J. Biol. Chem. 279, 27549-27559 (2004). 

     상세보기

121. J. Neurosci. H Aleyasin 24 2963 2004 10.1523/JNEUROSCI.0155-04.2004 Aleyasin, H. et al. Nuclear factor-κB modulates the p53 response in neurons exposed to DNA damage. J. Neurosci. 24, 2963-2973 (2004). 

     상세보기

122. Mol. Cell. Biol. S Shetty 25 5404 2005 10.1128/MCB.25.13.5404-5416.2005 Shetty, S. et al. Transcription factor NF-κB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol. Cell. Biol. 25, 5404-5416 (2005). 

     상세보기

123. Mol. Cell. Biol. B Eymin 26 4339 2006 10.1128/MCB.02240-05 Eymin, B. et al. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol. Cell. Biol. 26, 4339-4350 (2006). 

     상세보기

124. Trends Endocrinol. Metab. G Pascual 17 321 2006 10.1016/j.tem.2006.08.005 Pascual, G. & Glass, C. K. Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol. Metab. 17, 321-327 (2006). Clear and concise discussion of the complex relationship between nuclear receptors and the NF-κB pathway. 

     상세보기

125. Endocrine Rev. K De Bosscher 24 488 2003 10.1210/er.2002-0006 De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocrine Rev. 24, 488-522 (2003). 

     상세보기

126. J. Allergy Clin. Immunol. K Ito 117 522 2006 10.1016/j.jaci.2006.01.032 Ito, K., Chung, K. F. & Adcock, I. M. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 117, 522-543 (2006). 

     상세보기

127. Science N Auphan 270 286 1995 10.1126/science.270.5234.286 Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. & Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270, 286-290 (1995). 

     상세보기

128. Science RI Scheinman 270 283 1995 10.1126/science.270.5234.283 Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. & Baldwin, A. S. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286 (1995). 

     상세보기

129. J. Biol. Chem. KA Sheppard 273 29291 1998 10.1074/jbc.273.45.29291 Sheppard, K. A. et al. Nuclear integration of glucocorticoid receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273, 29291-29294 (1998). 

     상세보기

130. Cell S Ogawa 122 707 2005 10.1016/j.cell.2005.06.029 Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721 (2005). 

     상세보기

131. Mol. Cell. Biol. K Ito 20 6891 2000 10.1128/MCB.20.18.6891-6903.2000 Ito, K., Barnes, P. J. & Adcock, I. M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20, 6891-6903 (2000). 

     상세보기

132. Genes Dev. HF Luecke 19 1116 2005 10.1101/gad.1297105 Luecke, H. F. & Yamamoto, K. R. The glucocorticoid receptor blocks P-TEFb recruitment by NFκB to effect promoter-specific transcriptional repression. Genes Dev. 19, 1116-1127 (2005). 

     상세보기

133. Biochem. Pharmacol. BB Aggarwal 71 1397 2006 10.1016/j.bcp.2006.02.009 Aggarwal, B. B. & Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421 (2006). 

     상세보기

134. Curr. Opin. Hematol. RE Davis 9 333 2002 10.1097/00062752-200207000-00011 Davis, R. E. & Staudt, L. M. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr. Opin. Hematol. 9, 333-338 (2002). 

     상세보기

135. Cancer Res. JL Hanson 64 7248 2004 10.1158/0008-5472.CAN-03-3898 Hanson, J. L., Hawke, N. A., Kashatus, D. & Baldwin, A. S. The nuclear factor κB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Cancer Res. 64, 7248-7255 (2004). 

     상세보기

136. Cancer Lett. FR Greten 206 193 2004 10.1016/j.canlet.2003.08.029 Greten, F. R. & Karin, M. The IKK/NF-κB activation pathway - a target for prevention and treatment of cancer. Cancer Lett. 206, 193-199 (2004). 

     상세보기